#None #Faruqi & Faruqi #Nano-X Imaging #NNOX

Urgent Action for Investors in Nano-X Imaging

Faruqi & Faruqi LLP, a prominent national securities law firm, has issued an important notice for investors involved with Nano-X Imaging Ltd. (NASDAQ: NNOX). As part of their ongoing investigation, the firm is urging affected investors to consider their legal options regarding a pending class action lawsuit set to address several alleged misconducts by the company and its executives.

The deadline to file for lead plaintiff status in this federal securities class action case is set for August 11, 2026. This date is crucial for any investor who purchased or acquired Nano-X securities between March 31, 2025, and April 17, 2026, and has faced resultant financial losses.

The Allegations Against Nano-X Imaging

The crux of the allegations revolves around claims that Nano-X and its executives misled investors about the company’s operational efficiency and product demand. Specifically, it is alleged that the firm's public statements exaggerated reported efficiency gains and obscured real issues within their manufacturing and production processes. Some of the specific claims made include:
1. Overstating Efficiency Gains: The lawsuit asserts that the company misrepresented the actual efficiency gains within its operations.
2. Misleading Demand Reporting: Executives allegedly did not fully disclose that the manufacturing processes were out of sync with real demand for their products.
3. Rising Operational Costs: The lawsuit claims that Nano-X was experiencing unexpected increases in operational costs and cash burn rates due to these misalignments.
4. Impending Restructure Necessity: Statements from the company regarding operational health have reportedly created a false sense of security amidst foreseen restructuring necessities, which could lead to significant financial implications.

This widespread misrepresentation has culminated in significant stock price decreases. Following a release of their fourth-quarter financial results for 2025, in which Nano-X reported a net loss of $33.4 million—largely attributed to a $17.5 million impairment charge—the stock price saw a notable drop of nearly 24% within days.

What Investors Should Do

Affected investors are encouraged to reach out to Faruqi & Faruqi to discuss their options for participation in this lawsuit. Prospective lead plaintiffs will need to act swiftly and file a motion with the court by the aforementioned deadline. However, it’s crucial to highlight that participation in the lawsuit does not necessitate leading the case; all affected investors can file claims irrespective of their lead plaintiff status.

Furthermore, parties with knowledge regarding Nano-X's situation are invited to contact the firm, including whistleblowers and former employees who may provide valuable insights.

Seeking Guidance on Legal Rights

If you have engaged with Nano-X securities during the specified class period and are concerned about your investments, consider assessing your transaction records and preserving relevant documentation. For many, consulting experienced legal counsel may provide clarity and guidance on navigating potential claims and maximizing recovery options.

Faruqi & Faruqi, LLP has a solid track record of recovering substantial sums for investors in similar situations, making them a trusted ally in pursuing justice. Should you wish to discuss your legal rights further, feel free to reach out to the firm at their dedicated contact numbers.

For ongoing updates and information about the Nano-X Imaging class action lawsuit, visit Faruqi & Faruqi's website. Time is of the essence, and affected investors are urged to act promptly to secure their potential claims.